Scientists compared 51 longevity studies with a variety of ageing biomarkers to determine which biom
Recently, there have been several recent developments in the field of international medical health that continue to attract the attention of the industry and the public. Large-scale comparisons of human lifespan studies reveal why certain epigenetic clocks are able to detect biological changes much more consistently, while other epigenetic clocks are unable to do so. In a recent study published in the journal Nature Medicine, researchers examined the response of metabolic aging markers in old age to interventions that promote life expectancy or health time ranges.
Timely clock training to predict death or ageing rates shows the strongest response to interventions. DNA m is a particularly strong response of biomarkers to lifestyle and drug interventions, while pre-population health also affects the response to biomarkers. These findings can guide further trials of selective interventions and DNA m biomarkers, which may shorten study time and sample size while helping researchers select the appropriate research population.
Improvements in the understanding of lifespan interventions for biomarker responses may also help identify DNA m biomarkers that may ultimately be suitable for replacement in aging studies. Using aging biomarkers, researchers may be able to assess the effects of lifespan interventions on biomarker responses more quickly without the need for long trials, which may sometimes span decades. However, researchers must evaluate the response of aging biomarkers, including Epigenetic Clocks, to these interventions in order to use them as alternative endpoints in clinical trials.
Using alternative endpoints that predict longer-term outcomes with more short-term measurements may speed up testing and clinical translation of interventions. However, most previous studies have explored biomarkers with risk factors, disease rates, and mortality rates, clocks, or inconsistent use of time panels, which limits the comparative approach to different studies. In this study, researchers compiled a TranslAGE database containing 51 long-term intervention studies to assess the mechanisms of response of genomic aging biomarkers to human lifespan intervention.
Using this database, they calculated the study's epigenetic clocks from 16 Epigenetic Clocks (EPCs). They also evaluated 94 DNAM Biomarkers to investigate the biological processes that may explain changes in Epigenetic Clocks and EPCs. The TranslAGE database contains data from European Molecular Biology Laboratories (EMBL), Gene Expression Laboratories (GEO) and TruDiagnostic clinical trials.
Two-generation timepiece panels include first-generation Horvath and Hannum clocks and second-generation clocks (e. g. , Chen et al.
, 2009). Please note that the above content is based on international public research and is for reference in HealthCop, and does not constitute a clinical recommendation. If you have any health questions, please consult a professional medical professional.
